Talis Biomedical Corporation Increase (Decrease) in Other Noncurrent Assets
Talis Biomedical Corporation reported Increase (Decrease) in Other Noncurrent Assets of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-28.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2024-03-28
- Talis Biomedical Corporation increase (decrease) in other noncurrent assets for the quarter ending 2023-12-31 was $0.00, a 100.00% decline year-over-year.
- Talis Biomedical Corporation increase (decrease) in other noncurrent assets for the quarter ending 2023-03-31 was $0.00.
- Talis Biomedical Corporation increase (decrease) in other noncurrent assets for the quarter ending 2022-12-31 was $1.72M, a 62.01% decline year-over-year.
- Talis Biomedical Corporation increase (decrease) in other noncurrent assets for the quarter ending 2022-09-30 was $0.00.
- Talis Biomedical Corporation increase (decrease) in other noncurrent assets for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- Talis Biomedical Corporation increase (decrease) in other noncurrent assets for fiscal 2022 was $741.00K, a 86.55% decline from fiscal 2021.
- Talis Biomedical Corporation increase (decrease) in other noncurrent assets for fiscal 2021 was $5.51M.
- Talis Biomedical Corporation increase (decrease) in other noncurrent assets for fiscal 2020 was -$91.00K.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $0.00 10-K · filed 2024-03-28 | ||
| 2023-09-30 | $0.00 10-Q · filed 2023-11-14 | |||
| 2023-03-31 | $0.00 10-Q · filed 2023-05-11 | $1.72M derived: sum of 2 quarters · filed 2024-03-28 | $1.72M derived: sum of 3 quarters · filed 2024-03-28 | $1.72M derived: sum of 4 quarters · filed 2024-03-28 |
| 2022-12-31 | $1.72M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $1.72M derived: sum of 2 quarters · filed 2024-03-28 | $1.72M derived: sum of 3 quarters · filed 2024-03-28 | $741.00K 10-K · filed 2024-03-28 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $1.00K derived: sum of 2 quarters · filed 2023-11-14 | -$980.00K 10-Q · filed 2023-11-14 | $3.55M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$980.00K 10-Q · filed 2023-08-10 | $3.55M derived: sum of 3 quarters · filed 2023-08-10 | $3.55M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | -$981.00K 10-Q · filed 2023-05-11 | $3.55M derived: sum of 2 quarters · filed 2023-05-11 | $3.55M derived: sum of 3 quarters · filed 2023-05-11 | $3.55M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $4.53M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $4.53M derived: sum of 2 quarters · filed 2022-11-03 | $4.53M derived: sum of 3 quarters · filed 2022-11-03 | $5.51M 10-K · filed 2022-03-15 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $0.00 derived: sum of 2 quarters · filed 2022-11-03 | $981.00K 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $981.00K 10-Q · filed 2022-08-02 | ||
| 2021-03-31 | $981.00K 10-Q · filed 2022-05-10 | |||
| 2020-12-31 | -$91.00K 10-K · filed 2022-03-15 | |||
| 2020-06-30 | $249.00K 10-Q · filed 2021-08-10 |